Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 732

1.

The standing of percutaneous pulmonary valve implantation compared to surgery in a non-preselected cohort with dysfunctional right ventricular outflow tract - Reasons for failure and contraindications.

Haas NA, Vcasna R, Laser KT, Blanz U, Herrmann FE, Jakob A, Fischer M, Kanaan M, Lehner A.

J Cardiol. 2019 Jun 20. pii: S0914-5087(19)30116-9. doi: 10.1016/j.jjcc.2019.03.021. [Epub ahead of print]

PMID:
31230902
2.

A word of caution: diabolic behaviour of AndraStents®: inflation of supporting balloon leads to "diabolo"-misconfiguration of the stent.

Happel CM, Zunzunegui Martínez JL, Del Cerro MJ, Schranz D, Khalil M, Ballesteros F, Pardeiro CA, Bertram H, Beerbaum P, Haas NA.

Cardiol Young. 2019 Jun 20:1-5. doi: 10.1017/S1047951119001264. [Epub ahead of print]

PMID:
31218985
3.

Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation.

Correa AF, Jegede O, Haas NB, Flaherty KT, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG.

J Clin Oncol. 2019 Jun 19:JCO1900107. doi: 10.1200/JCO.19.00107. [Epub ahead of print]

PMID:
31216227
4.

The risk of infective endocarditis following interventional pulmonary valve implantation: A meta-analysis.

Lehner A, Haas NA, Dietl M, Jakob A, Schulze-Neick I, Dalla Pozza R, Rodriguez SF, Fischer M.

J Cardiol. 2019 May 18. pii: S0914-5087(19)30114-5. doi: 10.1016/j.jjcc.2019.04.007. [Epub ahead of print] Review.

PMID:
31113702
5.

The Interaction Between Craniofacial Computed Tomographic Dimensional Parameters and BMI in Obstructive Sleep Apnea.

Ben Ner D, Carmel-Neiderman NN, Fliss DM, Haas N, Rosenzweig E.

J Maxillofac Oral Surg. 2019 Jun;18(2):299-306. doi: 10.1007/s12663-018-1140-1. Epub 2018 Aug 27.

PMID:
30996555
6.

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Patel HD, Puligandla M, Shuch BM, Leibovich BC, Kapoor A, Master VA, Drake CG, Heng DY, Lara PN, Choueiri TK, Maskens D, Singer EA, Eggener SE, Svatek RS, Stadler WM, Cole S, Signoretti S, Gupta RT, Michaelson MD, McDermott DF, Cella D, Wagner LI, Haas NB, Carducci MA, Harshman LC, Allaf ME.

Future Oncol. 2019 May;15(15):1683-1695. doi: 10.2217/fon-2018-0951. Epub 2019 Apr 10.

PMID:
30968729
7.

The Creation of an Interatrial Right-To-Left Shunt in Patients with Severe, Irreversible Pulmonary Hypertension: Rationale, Devices, Outcomes.

Lehner A, Schulze-Neick I, Fischer M, Fernandez-Rodriguez S, Ulrich S, Haas NA, Jakob A.

Curr Cardiol Rep. 2019 Mar 18;21(5):31. doi: 10.1007/s11886-019-1118-8. Review.

PMID:
30887235
8.

Disability-Adjusted Life Years Following Adult Out-of-Hospital Cardiac Arrest in the United States.

Coute RA, Nathanson BH, Panchal AR, Kurz MC, Haas NL, McNally B, Neumar RW, Mader TJ.

Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e004677. doi: 10.1161/CIRCOUTCOMES.118.004677.

PMID:
30859852
9.

Microcatheter-assisted stenting of the tortuous vertical ductus arteriosus via femoral access in a duct-dependent pulmonary circulation.

Haas NA, Fernandez-Rodriguez S, Dalla Pozza R, Fischer M, Ulrich S, Jakob A, Lehner A.

Int J Cardiol. 2019 Jun 15;285:103-107. doi: 10.1016/j.ijcard.2019.01.062. Epub 2019 Jan 25.

PMID:
30851992
10.

An IL-6 receptor antagonist attenuates postpartum anhedonia, but has no effect on anhedonia precipitated by subchronic stress in female rats.

Gomez J, Haas NA, Schwarz JM.

Psychopharmacology (Berl). 2019 Mar 4. doi: 10.1007/s00213-019-05194-3. [Epub ahead of print]

PMID:
30830260
11.

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.

Martínez Chanzá N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC.

Lancet Oncol. 2019 Apr;20(4):581-590. doi: 10.1016/S1470-2045(18)30907-0. Epub 2019 Feb 28.

PMID:
30827746
12.

Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study.

Meyer K, Volkmann A, Hufnagel M, Schachinger E, Klau S, Horstmann J, Berner R, Fischer M, Lehner A, Haas N, Ulrich S, Jakob A.

BMC Pediatr. 2019 Feb 26;19(1):66. doi: 10.1186/s12887-019-1438-2.

13.

Risk Factors and Outcome of Post Fallot Repair Junctional Ectopic Tachycardia (JET).

Paluszek C, Brenner P, Pichlmaier M, Haas NA, Dalla-Pozza R, Hagl C, Hakami L.

World J Pediatr Congenit Heart Surg. 2019 Jan;10(1):50-57. doi: 10.1177/2150135118813124.

PMID:
30799715
14.

Diastereoselective Control of Tetraphenylethene Reactivity by Metal Template Self-Assembly.

Kennedy ADW, de Haas N, Iranmanesh H, Luis ET, Shen C, Wang P, Price JR, Donald WA, Andréasson J, Huang F, Beves JE.

Chemistry. 2019 Apr 17;25(22):5708-5718. doi: 10.1002/chem.201806259. Epub 2019 Mar 27.

PMID:
30775812
15.

Epinephrine Administered for Anaphylaxis Unmasking a Type 1 Brugada Pattern on Electrocardiogram.

Bui PV, Haas NL, Herrman NWC, Macias M, Hoch V, Schaeffer W, Wallace C.

J Emerg Med. 2019 Apr;56(4):444-447. doi: 10.1016/j.jemermed.2018.12.045. Epub 2019 Feb 10.

PMID:
30755346
16.

Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.

Haas NB, Appleman LJ, Stein M, Redlinger M, Wilks M, Xu X, Onorati A, Kalavacharla A, Kim T, Zhen CJ, Kadri S, Segal JP, Gimotty PA, Davis LE, Amaravadi RK.

Clin Cancer Res. 2019 Apr 1;25(7):2080-2087. doi: 10.1158/1078-0432.CCR-18-2204. Epub 2019 Jan 11.

PMID:
30635337
17.

Association between age and sex and mortality after adjuvant therapy for renal cancer.

Mamtani R, Wang XV, Gyawali B, DiPaola RS, Epperson CN, Haas NB, Dutcher JP.

Cancer. 2019 May 15;125(10):1637-1644. doi: 10.1002/cncr.31955. Epub 2019 Jan 8.

PMID:
30620389
18.

Edwards Sapien 3 transcatheter aortic valve implantation for management of severe aortic regurgitation in a teenage patient with corrected atrioventricular septal defect and progressive left ventricular dysfunction.

Lehner A, Herrmann FE, Mehilli J, Haas NA.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):E244-E247. doi: 10.1002/ccd.27975. Epub 2018 Nov 20.

PMID:
30461164
19.

Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN 3 transcatheter heart valve system.

Hascoet S, Dalla Pozza R, Bentham J, Carere RG, Kanaan M, Ewert P, Biernacka EK, Kretschmar O, Deutsch C, Lecerf F, Lehner A, Kantzis M, Kurucova J, Thoenes M, Bramlage P, Haas NA.

EuroIntervention. 2019 Jan 20;14(13):1378-1385. doi: 10.4244/EIJ-D-18-01035.

20.

Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.

Gomes D, von Kries R, Delius M, Mansmann U, Nast M, Stubert M, Langhammer L, Haas NA, Netz H, Obermeier V, Kuhle S, Holdt LM, Teupser D, Hasbargen U, Roscher AA, Ensenauer R.

PLoS Med. 2018 Oct 29;15(10):e1002681. doi: 10.1371/journal.pmed.1002681. eCollection 2018 Oct.

21.

Perioperative Therapy in Renal Cell Carcinoma: What Do We Know, What Have We Learned, What's Next?

Haas NB, Uzzo RG.

J Clin Oncol. 2018 Oct 29:JCO2018789131. doi: 10.1200/JCO.2018.78.9131. [Epub ahead of print]

PMID:
30372398
22.

A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours.

Maity A, Mick R, Huang AC, George SM, Farwell MD, Lukens JN, Berman AT, Mitchell TC, Bauml J, Schuchter LM, O'Hara M, Lin LL, Demichele A, Christodouleas JP, Haas NB, Patsch DM, Hahn SM, Minn AJ, Wherry EJ, Vonderheide RH.

Br J Cancer. 2018 Nov;119(10):1200-1207. doi: 10.1038/s41416-018-0281-9. Epub 2018 Oct 15.

PMID:
30318516
23.

Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial.

Narayan V, Puligandla M, Haas NB, Subramanian P, DiPaola RS, Uzzo R.

J Urol. 2019 Jan;201(1):62-68. doi: 10.1016/j.juro.2018.08.041.

PMID:
30130544
24.

Feasibility, safety and diagnostic impact of endomyocardial biopsies for the diagnosis of myocardial disease in children and adolescents.

Mueller GC, Michel-Behnke I, Knirsch W, Haas NA, Abdul-Khaliq H, Gitter R, Dittrich S, Dähnert I, Uhlemann F, Schubert S, Tarusinov G, Happel C, Bertram H, Sieverding L, Eicken A, Kozlik-Feldmann R, Weil J.

EuroIntervention. 2018 Nov 20;14(10):1089-1095. doi: 10.4244/EIJ-D-18-00128.

25.

The risk of bacterial endocarditis after percutaneous and surgical biological pulmonary valve implantation.

Haas NA, Bach S, Vcasna R, Laser KT, Sandica E, Blanz U, Jakob A, Dietl M, Fischer M, Kanaan M, Lehner A.

Int J Cardiol. 2018 Oct 1;268:55-60. doi: 10.1016/j.ijcard.2018.04.138.

PMID:
30041803
26.

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study.

Hansen AR, Massard C, Ott PA, Haas NB, Lopez JS, Ejadi S, Wallmark JM, Keam B, Delord JP, Aggarwal R, Gould M, Yang P, Keefe SM, Piha-Paul SA.

Ann Oncol. 2018 Aug 1;29(8):1807-1813. doi: 10.1093/annonc/mdy232.

PMID:
29992241
27.

Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR®).

Lehner A, Schulze-Neick I, Haas NA.

Cardiol Young. 2018 Aug;28(8):1062-1066. doi: 10.1017/S1047951118000720. Epub 2018 Jul 4.

PMID:
29972113
28.

Symptomatic Cholelithiasis of a Remnant Gallbladder after Open Cholecystectomy.

Upchurch CP, Haas NL, Magnone G, Compton J.

J Emerg Med. 2018 Sep;55(3):e71-e73. doi: 10.1016/j.jemermed.2018.05.028. Epub 2018 Jun 23.

PMID:
29941371
29.

Atrial flow regulator for failing Fontan circulation: an initial European experience.

Manuri L, Calaciura RE, De Zorzi A, Oreto L, Raponi M, Lehner A, Haas N, Agati S.

Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):761-764. doi: 10.1093/icvts/ivy165.

PMID:
29860487
30.

Hand Surgeons Performing More Open Carpal Tunnel Releases Do Not Show Better Patient Outcomes.

Evers S, Jansen MC, Slijper HP, de Haas N, Smit X, Porsius JT, Hovius SER, Amadio PC, Selles RW.

Plast Reconstr Surg. 2018 Jun;141(6):1439-1446. doi: 10.1097/PRS.0000000000004369.

31.

Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis.

Sun M, Marconi L, Eisen T, Escudier B, Giles RH, Haas NB, Harshman LC, Quinn DI, Larkin J, Pal SK, Powles T, Ryan CW, Sternberg CN, Uzzo R, Choueiri TK, Bex A.

Eur Urol. 2018 Nov;74(5):611-620. doi: 10.1016/j.eururo.2018.05.002. Epub 2018 May 18.

PMID:
29784193
32.

Edwards Sapien XT® pulmonic valve compression after resuscitation and successful redilatation.

Lehner A, Kantzis M, Haas NA.

Catheter Cardiovasc Interv. 2018 Sep 1;92(3):522-525. doi: 10.1002/ccd.27644. Epub 2018 May 18.

PMID:
29774980
33.

Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.

Catino AB, Hubbard RA, Chirinos JA, Townsend R, Keefe S, Haas NB, Puzanov I, Fang JC, Agarwal N, Hyman D, Smith AM, Gordon M, Plappert T, Englefield V, Narayan V, Ewer S, ElAmm C, Lenihan D, Ky B.

Circ Heart Fail. 2018 Mar;11(3):e004408. doi: 10.1161/CIRCHEARTFAILURE.117.004408.

34.

The Two-Bag Method for Treatment of Diabetic Ketoacidosis in Adults.

Haas NL, Gianchandani RY, Gunnerson KJ, Bassin BS, Ganti A, Hapner C, Boyd C, Cranford JA, Whitmore SP.

J Emerg Med. 2018 May;54(5):593-599. doi: 10.1016/j.jemermed.2018.01.004. Epub 2018 Apr 5.

PMID:
29628184
35.

Bedside Ultrasound Diagnosis of Complete Achilles Tendon Tear in a 25-Year-Old Man with Calf Injury.

Odom M, Haas N, Phillips K.

J Emerg Med. 2018 May;54(5):694-696. doi: 10.1016/j.jemermed.2018.01.028. Epub 2018 Apr 5. No abstract available.

PMID:
29627350
36.

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.

Hussain M, Tangen CM, Thompson IM Jr, Swanson GP, Wood DP, Sakr W, Dawson NA, Haas NB, Flaig TW, Dorff TB, Lin DW, Crawford ED, Quinn DI, Vogelzang NJ, Glode LM.

J Clin Oncol. 2018 May 20;36(15):1498-1504. doi: 10.1200/JCO.2017.76.4126. Epub 2018 Apr 6.

37.

Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population.

Buti S, Puligandla M, Bersanelli M, DiPaola RS, Manola J, Taguchi S, Haas NB.

Ann Oncol. 2018 Jul 1;29(7):1604. doi: 10.1093/annonc/mdx799. No abstract available.

PMID:
29608641
38.

Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805.

Estabrook R, Cella D, Zhao F, Manola J, DiPaola RS, Wagner LI, Haas NB.

Qual Life Res. 2018 Jun;27(6):1589-1597. doi: 10.1007/s11136-018-1817-4. Epub 2018 Mar 5.

39.

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma.

Sternberg CN, Donskov F, Haas NB, Doehn C, Russo P, Elmeliegy M, Baneyx G, Banerjee H, Aimone P, Motzer RJ.

Clin Cancer Res. 2018 Jul 1;24(13):3005-3013. doi: 10.1158/1078-0432.CCR-17-2652. Epub 2018 Jan 12.

PMID:
29330204
40.

Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.

Zhao F, Cella D, Manola J, DiPaola RS, Wagner LI, Haas NSB.

Support Care Cancer. 2018 Jun;26(6):1889-1895. doi: 10.1007/s00520-017-4027-7. Epub 2017 Dec 23.

41.

Centile Curves for Velocity-Time Integral Times Heart Rate as a Function of Ventricular Length: The Use of Minute Distance Is Advantageous to Enhance Clinical Reliability in Children.

Solinski A, Klusmeier E, Horst JP, Körperich H, Haas NA, Kececioglu D, Laser KT.

J Am Soc Echocardiogr. 2018 Jan;31(1):105-112.e2. doi: 10.1016/j.echo.2017.09.011. Epub 2017 Nov 20.

42.

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.

Jilaveanu LB, Puligandla M, Weiss SA, Wang XV, Zito C, Flaherty KT, Boeke M, Neumeister V, Camp RL, Adeniran A, Pins M, Manola J, DiPaola RS, Haas NB, Kluger HM.

Clin Cancer Res. 2018 Jan 1;24(1):217-223. doi: 10.1158/1078-0432.CCR-17-1555. Epub 2017 Oct 24.

43.

A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors.

Yam C, Xu X, Davies MA, Gimotty PA, Morrissette JJD, Tetzlaff MT, Wani KM, Liu S, Deng W, Buckley M, Zhao J, Amaravadi RK, Haas NB, Kudchadkar RR, Pavlick AC, Sosman JA, Tawbi H, Walker L, Schuchter LM, Karakousis GC, Gangadhar TC.

Clin Cancer Res. 2018 Jan 1;24(1):22-32. doi: 10.1158/1078-0432.CCR-17-1807. Epub 2017 Oct 19.

44.

Recent advances in localized RCC: A focus on VEGF and immuno-oncology therapies.

Subramanian P, Haas NB.

Urol Oncol. 2018 Jan;36(1):23-30. doi: 10.1016/j.urolonc.2017.09.008. Epub 2017 Oct 16. Review.

PMID:
29051029
45.

Using Electronic Health Records and Clinical Decision Support to Provide Return-to-Work Guidance for Primary Care Practitioners for Patients With Low Back Pain.

McLellan RK, Haas NS, Kownacki RP, Pransky GS, Talmage JB, Dreger M.

J Occup Environ Med. 2017 Nov;59(11):e240-e244. doi: 10.1097/JOM.0000000000001180. Review.

46.

Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system.

Haas NA, Carere RG, Kretschmar O, Horlick E, Rodés-Cabau J, de Wolf D, Gewillig M, Mullen M, Lehner A, Deutsch C, Bramlage P, Ewert P.

Int J Cardiol. 2018 Jan 1;250:86-91. doi: 10.1016/j.ijcard.2017.10.015. Epub 2017 Oct 6.

PMID:
29017776
47.

Is mesocardia with left-sided caval vein draining to coronary sinus a contraindication for a percutaneous pulmonary valve implantation? A case description.

Kantzis M, Happel CM, Haas NA.

Cardiol Young. 2018 Feb;28(2):229-233. doi: 10.1017/S1047951117001743. Epub 2017 Oct 4.

PMID:
28974283
48.

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.

Voss MH, Hussain A, Vogelzang N, Lee JL, Keam B, Rha SY, Vaishampayan U, Harris WB, Richey S, Randall JM, Shaffer D, Cohn A, Crowell T, Li J, Senderowicz A, Stone E, Figlin R, Motzer RJ, Haas NB, Hutson T.

Ann Oncol. 2017 Nov 1;28(11):2754-2760. doi: 10.1093/annonc/mdx493.

PMID:
28950297
49.

Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population.

Buti S, Puligandla M, Bersanelli M, DiPaola RS, Manola J, Taguchi S, Haas NB.

Ann Oncol. 2017 Nov 1;28(11):2747-2753. doi: 10.1093/annonc/mdx492.

50.

Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity.

Hato SV, Figdor CG, Takahashi S, Pen AE, Halilovic A, Bol KF, Vasaturo A, Inoue Y, de Haas N, Verweij D, Van Herpen CML, Kaanders JH, van Krieken JHJM, Van Laarhoven HWM, Hooijer GKJ, Punt CJA, Asai A, de Vries IJM, Lesterhuis WJ.

Oncotarget. 2017 May 7;8(33):54434-54443. doi: 10.18632/oncotarget.17661. eCollection 2017 Aug 15.

Supplemental Content

Support Center